MICHELLE CIVELLO: Open Payments
NPI 1396051868 · WALKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 36 payments from 19 companies in 2025. Trend: 2023 $380 · 2024 $485 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $138 |
| Abbott Laboratories | 3 | $78 |
| Lilly USA, LLC | 5 | $77 |
| Radius Health, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| PFIZER INC. | 1 | $24 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, VRAYLAR, CREON, Tymlos, Kerendia, STRENSIQ, CRENESSITY.
Industry payments across LA — which companies pay providers there.
